MARCH Trial

A A A

MARCH Trial

Welcome to the MARCH Trial website.The MARCH Trial is a international, multicentre, prospective randomised controlled trial comparing laparoscopic and open inguinal hernia repair in infants less than one year old.

Please follow the links below:

RANDOMISE A NEW PATIENT

About The MARCH Trial

MARCH stands for:

Minimal

Access

Repair of

Contralateral

Hernias

The trial is an international collaboration designed to answer the question:

In infants less than 1 year old with unilateral inguinal hernia,

does laparoscopic repair with closure of contralateral patent processus vaginalis if present,

prevent development of contralateral inguinal hernia?

MARCH is a prospective randomised controlled trial with 8 participating centres in 3 countries (UK, Austria and Italy). The lead centre is the Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.

With parental consent, 360 infants with unilateral inguinal hernia will be randomised to receive either open or laparoscopic repair. The infants will be monitored for the development of contralateral inguinal hernia for 3 years after surgery.

Several secondary outcome measures will also be compared between the two treatments. (See MARCH Trial Protocol for full details.)

Randomise a New Patient

To randomise a new patient into the MARCH Trial you will need the following:

MARCH Trial Login Name & Password for your centre
All patient information from: Form A: Randomisation
The patient must meet all the inclusion criteria and none of the exclusion criteria
RANDOMISE A NEW PATIENT NOW